Danish educational materials
From November 15th 2016 the Danish Medicines Agency published Danish educational materials for human medicinal products approved via the national procedure, the mutual recognition procedure and the decentralised procedure.
From January 1st 2023 and forward – and not retroactively - the Danish Medicines Agency also publishes Danish educational materials for human medicinal products approved via the centralised procedure.
The marketing authorisation holder has the overall responsibility for the educational material and for ensuring that it complies with the conditions of the marketing authorisation. The marketing authorisation holder also has the overall responsibility for ensuring that the Danish Medicines Agency has the latest accepted written educational material available for publication.
Please refer to the section Dansk uddannelsesmateriale for the accepted and published Danish educational materials
| Name | Medicine Type | Strength | Active substance | Mft owner | Publish Date |
| Tecartus | infusionsvæske, dispersion | 0.4 - 2.0 x 10^8 | Brexucabtagen autoleucel | Kite Pharma EU B.V. | 19/01/2024 |
| Tecentriq | koncentrat til infusionsvæske, opløsning | 1200 mg | Atezolizumab | Roche Registration GmbH | 14/08/2023 |
| Tecentriq | koncentrat til infusionsvæske, opløsning | 840 mg | Atezolizumab | Roche Registration GmbH | 14/08/2023 |
| TECVAYLI | injektionsvæske, opløsning | 90 mg/ml | Teclistamab | Janssen-Cilag International NV | 05/02/2024 |
| TECVAYLI | injektionsvæske, opløsning | 10 mg/ml | Teclistamab | Janssen-Cilag International NV | 05/02/2024 |
| Tenofovir disoproxil "Accordpharma" | filmovertrukne tabletter | 245 mg | TENOFOVIRDISOPROXILFUMARAT | Accord Healthcare B.V. | 14/08/2020 |
| Tenofovir disoproxil "Teva" | filmovertrukne tabletter | 245 mg | Tenofovir disoproxilphosphat | Teva B.V. | 11/07/2017 |
| Tepkinly | injektionsvæske, opløsning | 48 mg | Epcoritamab | AbbVie Deutschland GmbH & Co. KG | 06/03/2024 |
| Tepkinly | koncentrat til injektionsvæske, opløsning | 4 mg/0,8 ml | Epcoritamab | AbbVie Deutschland GmbH & Co. KG | 06/03/2024 |
| Teriflunomide "Sandoz" | filmovertrukne tabletter | 14 mg | Teriflunomid | Sandoz A/S | 18/10/2023 |
| Teriflunomide Mylan | filmovertrukne tabletter | 14 mg | Teriflunomid | Mylan Pharmaceuticals Limited | 11/10/2023 |
| Testosteron "Medical Valley" | injektionsvæske, opløsning | 1000 mg/4 ml | TESTOSTERONUNDECANOAT | Medical Valley Invest AB | 15/03/2024 |
| Testosterone "Teva" | injektionsvæske, opløsning | 1000 mg/4 ml | TESTOSTERONUNDECANOAT | Teva B.V. | 18/03/2024 |
| Thalidomid "Accord" | kapsler, hårde | 50 mg | THALIDOMID | Accord Healthcare B.V. | 30/06/2022 |
| Thalidomide BMS | kapsler, hårde | 50 mg | THALIDOMID | Bristol-Myers Squibb Pharma EEIG | 25/01/2024 |